A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
Clinical trial NCT02741791 · COMPLETED
Trial details
- NCT number
- NCT02741791
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-03-20
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.